{"transactions":[{"id":4618684,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-15T23:11:48.000Z","date":"2026-09-15","kind":"sale","planned":false,"acquired":false,"shares":906,"price":95.71,"value":86713.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":235478,"source":{"system":"sec-edgar","filing":"0000907654-26-000094","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2075401/000090765426000094/form4.xml","form_type":"4"}},{"id":671586,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-09-01T22:36:11.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant vests as to 1/4 of the underlying shares on April 3, 2025 and as to 1/48 of the underlying shares monthly from April 3, 2025."}],"balance_after":74996,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000907654-26-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000088/form4.xml","form_type":"4"}},{"id":671585,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-01T22:36:11.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":92.0134,"value":368053.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.60 to $92.59, inclusive."}],"balance_after":236384,"source":{"system":"sec-edgar","filing":"0000907654-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000088/form4.xml","form_type":"4"}},{"id":671584,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-01T22:36:11.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":91.0476,"value":91047.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.51 to $91.49, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":240384,"source":{"system":"sec-edgar","filing":"0000907654-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000088/form4.xml","form_type":"4"}},{"id":671583,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-01T22:36:11.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":7.8,"value":39000.0,"ownership":{"direct":true},"balance_after":241384,"source":{"system":"sec-edgar","filing":"0000907654-26-000088","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000088/form4.xml","form_type":"4"}},{"id":722020,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-07-01T23:58:02.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrant vests as to 1/4 of the underlying shares on April 3, 2025 and as to 1/48 of the underlying shares monthly from April 3, 2025."}],"balance_after":79996,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000907654-26-000069","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000069/form4.xml","form_type":"4"}},{"id":722019,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-01T23:58:02.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":500,"price":95.472,"value":47736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.40 to $95.51, inclusive."}],"balance_after":236384,"source":{"system":"sec-edgar","filing":"0000907654-26-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000069/form4.xml","form_type":"4"}},{"id":722018,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-01T23:58:02.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":2263,"price":94.7458,"value":214409.7454,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.38 to $95.19, inclusive."}],"balance_after":236884,"source":{"system":"sec-edgar","filing":"0000907654-26-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000069/form4.xml","form_type":"4"}},{"id":722017,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-01T23:58:02.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":2237,"price":93.8457,"value":209932.8309,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.29 to $94.26, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":239147,"source":{"system":"sec-edgar","filing":"0000907654-26-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000069/form4.xml","form_type":"4"}},{"id":722016,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-01T23:58:02.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":7.8,"value":39000.0,"ownership":{"direct":true},"balance_after":241384,"source":{"system":"sec-edgar","filing":"0000907654-26-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000069/form4.xml","form_type":"4"}},{"id":738557,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-06-15T22:51:40.000Z","date":"2026-06-15","kind":"sale","planned":false,"acquired":false,"shares":600,"price":69.69,"value":41814.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":236384,"source":{"system":"sec-edgar","filing":"0000907654-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000061/form4.xml","form_type":"4"}},{"id":796190,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-05-01T22:25:39.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The warrant vests as to 1/4 of the underlying shares on April 3, 2025 and as to 1/48 of the underlying shares monthly from April 3, 2025."}],"balance_after":84996,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000907654-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000037/form4.xml","form_type":"4"}},{"id":796189,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-01T22:25:39.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":68.48,"value":6848.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."}],"balance_after":236984,"source":{"system":"sec-edgar","filing":"0000907654-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000037/form4.xml","form_type":"4"}},{"id":796188,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-01T22:25:39.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":200,"price":67.155,"value":13431.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.11 to $67.20, inclusive."}],"balance_after":237084,"source":{"system":"sec-edgar","filing":"0000907654-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000037/form4.xml","form_type":"4"}},{"id":796187,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-01T22:25:39.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":400,"price":66.055,"value":26422.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.85 to $66.23, inclusive."}],"balance_after":237284,"source":{"system":"sec-edgar","filing":"0000907654-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000037/form4.xml","form_type":"4"}},{"id":796186,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-01T22:25:39.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":300,"price":65.1,"value":19530.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.85 to $65.28, inclusive."}],"balance_after":237684,"source":{"system":"sec-edgar","filing":"0000907654-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000037/form4.xml","form_type":"4"}},{"id":796185,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-01T22:25:39.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":64.1488,"value":115467.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.59 to $64.55, inclusive."}],"balance_after":237984,"source":{"system":"sec-edgar","filing":"0000907654-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000037/form4.xml","form_type":"4"}},{"id":796184,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-01T22:25:39.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":2200,"price":62.5843,"value":137685.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.33 to $62.83, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5) and (6) to this Form 4."}],"balance_after":239784,"source":{"system":"sec-edgar","filing":"0000907654-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000037/form4.xml","form_type":"4"}},{"id":796183,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-01T22:25:39.000Z","date":"2026-05-01","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":7.8,"value":39000.0,"ownership":{"direct":true},"balance_after":241984,"source":{"system":"sec-edgar","filing":"0000907654-26-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000037/form4.xml","form_type":"4"}},{"id":839732,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-17T20:08:09.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":600,"price":41.3,"value":24780.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units."}],"balance_after":236984,"source":{"system":"sec-edgar","filing":"0000907654-26-000031","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000031/form4.xml","form_type":"4"}},{"id":875460,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-03-02T23:47:50.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant vests as to 1/4 of the underlying shares on April 3, 2025 and as to 1/48 of the underlying shares monthly from April 3, 2025."}],"balance_after":89996,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000907654-26-000022","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000022/form4.xml","form_type":"4"}},{"id":875459,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:47:50.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":2675,"price":33.8077,"value":90435.5975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.66 to $34.33, inclusive."}],"balance_after":237584,"source":{"system":"sec-edgar","filing":"0000907654-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000022/form4.xml","form_type":"4"}},{"id":875458,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:47:50.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":2325,"price":33.2843,"value":77385.9975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.66 to $33.64, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":240259,"source":{"system":"sec-edgar","filing":"0000907654-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000022/form4.xml","form_type":"4"}},{"id":875457,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-02T23:47:50.000Z","date":"2026-03-02","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":7.8,"value":39000.0,"ownership":{"direct":true},"balance_after":242584,"source":{"system":"sec-edgar","filing":"0000907654-26-000022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000022/form4.xml","form_type":"4"}},{"id":932713,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-01-23T22:40:21.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/48 of the underlying shares monthly from January 1, 2026."}],"balance_after":130000,"derivative":{"exercise_price":34.39,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000907654-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000017/form4.xml","form_type":"4"}},{"id":932712,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-23T22:40:21.000Z","date":"2026-01-23","kind":"grant","planned":false,"acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant vests as to 1/16 of the shares on each March 14, June 14, September 14 and December 14 (or if not a trading day, the immediately preceding trading day)."}],"balance_after":237584,"source":{"system":"sec-edgar","filing":"0000907654-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000017/form4.xml","form_type":"4"}},{"id":955760,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Warrant (right to buy)","published_at":"2026-01-03T01:25:59.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrant vests as to 1/4 of the underlying shares on April 3, 2025 and as to 1/48 of the underlying shares monthly from April 3, 2025."}],"balance_after":94996,"derivative":{"exercise_price":7.8,"expiration_date":"2034-07-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000907654-26-000002","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000002/form4.xml","form_type":"4"}},{"id":955759,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-03T01:25:59.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":1108,"price":29.7536,"value":32966.9888,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.56 to $29.92, inclusive."}],"balance_after":205084,"source":{"system":"sec-edgar","filing":"0000907654-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000002/form4.xml","form_type":"4"}},{"id":955758,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-03T01:25:59.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":3144,"price":29.0814,"value":91431.9216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.55 to $29.50, inclusive."}],"balance_after":206192,"source":{"system":"sec-edgar","filing":"0000907654-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000002/form4.xml","form_type":"4"}},{"id":955757,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-03T01:25:59.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":8748,"price":28.166,"value":246396.168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on September 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.55 to $28.52, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4."}],"balance_after":209336,"source":{"system":"sec-edgar","filing":"0000907654-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000002/form4.xml","form_type":"4"}},{"id":955756,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-01-03T01:25:59.000Z","date":"2026-01-02","kind":"exercise","planned":true,"acquired":true,"shares":5000,"price":7.8,"value":39000.0,"ownership":{"direct":true},"balance_after":218084,"source":{"system":"sec-edgar","filing":"0000907654-26-000002","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000090765426000002/form4.xml","form_type":"4"}},{"id":1098518,"issuer":{"id":3781,"kind":"organization","name":"Oruka Therapeutics, Inc.","symbol":"ORKA"},"owners":[{"id":18149,"kind":"person","name":"Sandler Laura Lee","position":1,"cik":"0002075401","reported_name":"Sandler Laura Lee","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-07-02T01:26:04.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/4 of the underlying shares on July 1, 2026, and as to 1/48 of the underlying shares monthly thereafter."}],"balance_after":25000,"derivative":{"exercise_price":11.8,"expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-25-012406","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/907654/000106299325012406/form4.xml","form_type":"4"}}]}